According to Amylyx Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is $87.37 Million USD. a decrease over the revenue in the year 2023 that were of $0.38 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.